Lakewood-Amedex Biotherapeutics Inc (LABT) Stock Price, Quote & News

Company Profile

Lakewood-Amedex Biotherapeutics, Inc. operates as a clinical-stage biotechnology company that develops antimicrobial products in the United States. The company offers products from its Bisphosphocin class, a novel class of antimicrobial agents a broad range of infections, including those affecting the skin, bladder, and lungs. It also develops Nu-3, a topical antimicrobial for infected diabetic foot ulcers, which is in Phase 2b clinical trial. The company was formerly known as Lakewood-Amedex In...

Industry: Biotechnology

Sector: Healthcare

Phone: 941 225 2515

Website: lakewoodamedex.com

Address:

8031 Cooper Creek Blvd., Suite 103, University Park, United States

LargeSodaDrinker Aug. 7 at 3:01 AM

$LABT Yeah you fools always lie.... When it goes up, you'll magically claim you had a long position too....

1 · Reply

TurdSniper Aug. 7 at 12:18 AM

$LABT Looking to short this turd tomorrow ⬇💩

0 · Reply

kellyc09 Aug. 6 at 6:26 PM

$LABT Not sure when but just feel this stock is ready for a massive run. Had a few false breakouts but just seems like it’s being tested. Some PR would help

0 · Reply

TheSqueezeKingdom Aug. 5 at 3:33 PM

$LABT PR coming any moment, any day, any minute…and when it does, we’ll be selling at $6.50+ to FOMO chasers w/o the patience to get in low, exhibit patience, and reap the rewards.

1 · Reply

TheSqueezeKingdom Aug. 5 at 3:12 PM

$JLHL $LABT & $KIDZ UP NEXT

0 · Reply

TheSqueezeKingdom Aug. 5 at 2:36 PM

$LABT easy trip+

0 · Reply

therealrayfinkle Aug. 5 at 1:58 PM

$LABT 0 shares available to short at 776%? Am I seeing that correct?

1 · Reply

missrosie Aug. 5 at 1:13 PM

$LABT 👀

0 · Reply

TurdSniper Aug. 5 at 12:35 PM

$LABT Looks like a fake premarket pump on this turd 💩

0 · Reply

TheSqueezeKingdom Aug. 5 at 12:25 PM

Now onto our $LABT squeeze to $6+

0 · Reply

Why Is Penny Stock Lakewood-Amedex Biotherapeutics (LABT) Up Today?

2026-07-22T12:12:25.000Z - 18 days ago

Lakewood-Amedex announces resistance data for Nu-3

Jul 22, 2026, 8:02 AM EDT - 18 days ago

Lakewood-Amedex Biotherapeutics Highlights Nu-3 Resistance Data in Response to National Action Plan of Presidential Advisory Council on Combating Antibiotic Resistant Bacteria

2026-07-15T12:10:36.000Z - 25 days ago

Lakewood-Amedex announces preclinical data from Phase 2a clinical trial

Jul 15, 2026, 8:02 AM EDT - 25 days ago

Lakewood-Amedex Biotherapeutics Announces Preclinical Safety Data Supporting Clinical Dose Selection for Upcoming Phase 2a Trial of Nu-3 Gel

2026-07-07T12:10:31.000Z - 4 weeks ago

Lakewood-Amedex supports reintroduction of PASTEUR act

Jul 7, 2026, 8:02 AM EDT - 4 weeks ago

Lakewood-Amedex Biotherapeutics Supports Reintroduction of the PASTEUR Act and Focus on Combating Antimicrobial Resistance

Jun 25, 2026, 8:02 AM EDT - 6 weeks ago

Lakewood-Amedex Biotherapeutics Announces World-Renowned Expert David G. Armstrong, M.D.

2026-06-22T12:13:49.000Z - 6 weeks ago

Lakewood-Amedex Biotherapeutics announces new patent in Australia

Jun 22, 2026, 8:02 AM EDT - 6 weeks ago

Lakewood-Amedex Biotherapeutics Secures Composition of Matter Patent Protecting New Bisphosphocin® Compounds Being Developed for High-Need Antimicrobial Infections

2026-06-18T23:52:08.000Z - 7 weeks ago

Lakewood-amedex Biotherapeutics Inc trading halted, news pending

Jun 16, 2026, 8:02 AM EDT - 7 weeks ago

Lakewood-Amedex Biotherapeutics to Present at Life Sciences Virtual Investor Forum

2026-05-29T18:11:40.000Z - 2 months ago

Lakewood-Amedex Biotherapeutics building broad antimicrobial platform, CEO says

2026-05-29T18:05:31.000Z - 2 months ago

Meet Lakewood-Amedex Biotherapeutics: Fly exclusive with CEO Kelvin Cooper

2026-05-27T14:34:25.000Z - 2 months ago

Lakewood-Amedex Biotherapeutics issued two new patents

May 27, 2026, 8:02 AM EDT - 2 months ago

Lakewood-Amedex Expands Global IP Portfolio for Lead Candidate, Nu-3, Targeting Infected Diabetic Foot Ulcers

2026-05-18T12:12:33.000Z - 2 months ago

Lakewood-Amedex Biotherapeutics advances production of foot ulcer candidate Nu3

May 18, 2026, 8:02 AM EDT - 2 months ago

Lakewood-Amedex Biotherapeutics Announces Positive Data for the Advancement of Lead Candidate, Nu-3, in Infected Diabetic Foot Ulcers

May 12, 2026, 8:02 AM EDT - 3 months ago

Lakewood-Amedex Biotherapeutics Announces Agreement with PERI to Serve as CRO for Phase 2 Clinical Trial of Nu-3

2026-05-01T12:13:42.000Z - 3 months ago

Lakewood-Amedex Biotherapeutics’ lead candidate in foot ulcers shows efficacy

Apr 28, 2026, 7:33 AM EDT - 3 months ago

Lakewood-Amedex Biotherapeutics Appoints Joseph Tucker, Ph.D., to Board of Directors

ENVB

2026-04-27T13:56:19.000Z - 3 months ago

Lakewood-Amedex Biotherapeutics Inc. Common Stock trading halted, volatility trading pause

2026-04-27T13:44:15.000Z - 3 months ago

Lakewood-Amedex Biotherapeutics Inc. Common Stock trading resumes

Apr 23, 2026, 10:42 AM EDT - 3 months ago

Lakewood-Amedex Biotherapeutics Announces Direct Listing on Nasdaq; Shares Trading Under the Symbol "LABT"

Jan 9, 2026, 5:38 PM EST - 7 months ago

Lakewood-Amedex Biotherapeutics, Biotech Developing Novel Locally Delivered Antimicrobials for Resistant Infections and Chronic Wounds, Files for Nasdaq Capital Market IPO

Jan 9, 2026, 5:28 PM EST - 7 months ago

Lakewood-Amedex Biotherapeutics IPO Registration Document (S-1)

Jan 9, 2026, 3:33 PM EST - 7 months ago

Micro-cap biotech Lakewood-Amedex Biotherapeutics files for a Nasdaq direct listing

LargeSodaDrinker Aug. 7 at 3:01 AM

$LABT Yeah you fools always lie.... When it goes up, you'll magically claim you had a long position too....

1 · Reply

TurdSniper Aug. 7 at 12:18 AM

$LABT Looking to short this turd tomorrow ⬇💩

0 · Reply

kellyc09 Aug. 6 at 6:26 PM

$LABT Not sure when but just feel this stock is ready for a massive run. Had a few false breakouts but just seems like it’s being tested. Some PR would help

0 · Reply

TheSqueezeKingdom Aug. 5 at 3:33 PM

$LABT PR coming any moment, any day, any minute…and when it does, we’ll be selling at $6.50+ to FOMO chasers w/o the patience to get in low, exhibit patience, and reap the rewards.

1 · Reply

TheSqueezeKingdom Aug. 5 at 3:12 PM

$JLHL $LABT & $KIDZ UP NEXT

0 · Reply

TheSqueezeKingdom Aug. 5 at 2:36 PM

$LABT easy trip+

0 · Reply

therealrayfinkle Aug. 5 at 1:58 PM

$LABT 0 shares available to short at 776%? Am I seeing that correct?

1 · Reply

missrosie Aug. 5 at 1:13 PM

$LABT 👀

0 · Reply

TurdSniper Aug. 5 at 12:35 PM

$LABT Looks like a fake premarket pump on this turd 💩

0 · Reply

TheSqueezeKingdom Aug. 5 at 12:25 PM

Now onto our $LABT squeeze to $6+

0 · Reply

Stock_Catcher Aug. 5 at 12:20 PM

$LABT Thin

0 · Reply

ProfessorDman1 Aug. 4 at 6:08 PM

$LABT swing overnight idea up 10%+

0 · Reply

TraderBuckNKY Aug. 4 at 5:26 PM

$LABT ...?....

0 · Reply

m3gray Aug. 4 at 5:24 PM

$LABT PR coming AH

0 · Reply

stonksandchuckle Aug. 4 at 5:16 PM

$LABT lets go for a ride?

0 · Reply

TheSqueezeKingdom Aug. 4 at 4:25 PM

$LABT coming soon

0 · Reply

TurdSniper Aug. 3 at 6:46 PM

$LABT 194K shares traded on the day and the bulls think it's gonna run...this turd will slowly drop. Market Makers gota reel in unsuspecting investors first! 💩⬇

0 · Reply

m3gray Aug. 3 at 6:33 PM

$LABT I’ve slapped the ask 4 times. I need some help

0 · Reply

bigone123 Aug. 3 at 6:24 PM

$LABT when tooo sell

0 · Reply

bigone123 Aug. 3 at 6:23 PM

$LABT

0 · Reply

ProfessorDman1 Aug. 3 at 6:21 PM

$LABT This going go run .. Volume building up here … keep it on your radar now

1 · Reply

Market Cap	5.26M
Revenue (ttm)	0.00
Net Income (ttm)	-3.85M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	0.88
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	46,100
Avg Vol	1,831,016
Day's Range	N/A - N/A
Shares Out	2.37M
Stochastic %K	60%
Beta	N/A
Analysts	Strong Buy
Price Target	$12.00